Ahmad Habib
Family · Sacramento, CANPI 1164053880
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations.
Across 64 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$244
- Corcept Therapeutics$183
- Bayer$114
- Exact Sciences$112
- AbbVie$106
- Novo Nordisk$85
- plus $652 from 16 others
What the payments were for
- Food & beverage$1,498100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 9 | $244 |
| Corcept Therapeutics | 5 | $183 |
| Bayer | 4 | $114 |
| Exact Sciences | 5 | $112 |
| AbbVie | 6 | $106 |
| Novo Nordisk | 4 | $85 |
| Abbott | 3 | $77 |
| Amgen | 4 | $64 |
| Dexcom, Inc. | 2 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Pfizer | 3 | $56 |
| Incyte Corporation | 2 | $51 |
| AstraZeneca | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Kowa Pharmaceuticals America, Inc. | 2 | $34 |
| Lilly USA, LLC | 2 | $32 |
| Aimmune Therapeutics, Inc. | 1 | $29 |
| Organon | 1 | $23 |
| Boehringer Ingelheim | 1 | $22 |
| Lundbeck LLC | 1 | $20 |
| Phadia US Inc. | 1 | $20 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
How this compares
$1,498 in reported general payments places this provider in the 80th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $2,003 |
| Atorvastatin Calcium | 74 | $744 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 46 | $455 |
| Gabapentin | 35 | $394 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $378 |
| Amlodipine Besylate | 49 | $312 |
| Omeprazole | 19 | $260 |
| Escitalopram Oxalate | 15 | $256 |
| Losartan Potassium | 30 | $216 |
| Glipizide | 22 | $191 |
| Metformin Hcl | 38 | $190 |
| Levothyroxine Sodium | 14 | $186 |
| Metoprolol Succinate | 11 | $148 |
| Tamsulosin Hcl | 19 | $148 |
| Triamcinolone Acetonide | 15 | $145 |
Paid to pharmacies, not to this prescriber.
Other family in Sacramento
- Kim SchaferSacramento$288K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.